Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Roche Diagnostics

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled "Roche Diagnostics" involves the lease and provision of laboratory supplies and support services under the Indian Health Service. It is identified with the number 2025-AAP-GSU-SU-0015 and falls under the NAICS code 334516, which pertains to laboratory equipment manufacturing. The contract was forecasted on March 11, 2026, and is intended to support the operational needs of the Indian Health Service, although specific locations for performance are not detailed. Key contacts for this contract include James Selleck, serving as the program point of contact, and Misty Billy, the contracting officer responsible for overseeing the agreement. While the solicitation number and set-aside information are not provided, the contract outlines an important engagement for ensuring the availability of critical lab supplies and support services to enhance healthcare delivery within the Indian Health Service framework. Further details and updates are accessible through the official industry opportunity forecast portal.

General Info

Lease of lab equipment and support services for Indian Health Service under contract 2025-AAP-GSU-SU-0015.

Agency

Indian Health Service

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyIndian Health Service
Contacts2 people available
OfficeN/A
Organization / Agency
Indian Health Service
Office AddressN/A
Contacts
James Selleck
Misty BillyContracting Officer

Full Description

Show more
2025-AAP-GSU-SU-0015: Lease, Lab Supplies/Support Sv

Similar Contracts

NAICS: 334516
New
Federal
Long-Read RNA Sequencing Kits for CARD iNDI Brain Sample StudyThe National Institutes of Health, specifically the National Institute on Aging (NIA), has issued a Notice of Intent to Sole Source for the procurement of brand-name Oxford Nanopore long-read RNA sequencing consumables. This acquisition supports the Center for Alzheimer’s Disease and Related Dementias’ (CARD) induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI). The government plans to award a firm-fixed-price purchase order exclusively to Oxford Nanopore Technologies, Inc. for specific consumables including 171 PromethION Flow Cells and 114 units of the cDNA-PCR Sequencing Kit. These supplies are essential for conducting large-scale RNA sequencing on 600 postmortem human brain samples to advance research on Alzheimer’s, Parkinson’s, and brain aging by analyzing gene expression and isoform diversity. The consumables must meet stringent performance criteria: flow cells need to generate data with modal accuracy above 99% and be fully compatible with government-owned Oxford Nanopore PromethION 48 sequencers, while the sequencing kits must require minimal RNA input and accommodate six reactions each. Due to the proprietary nature of the Oxford Nanopore platform, compatible items from other manufacturers are not acceptable. The acquisition authority is based on regulations permitting a sole source award when only one responsible source exists, under 41 U.S.C. 3304(a)(1) and FAR 6.302-1. Interested parties other than Oxford Nanopore may submit capability statements proving their ability to meet all specified requirements by June 23, 2026. Submissions must demonstrate equivalency or authorized distribution and clear compatibility with the existing sequencing equipment. The government will review responses to decide whether to proceed with sole sourcing or consider competitive procurement, retaining full discretion in this decision.
National Institutes Of Health Olao

POSTED

about 20 hours ago

DEADLINE

in 12 days
View Details